InvestorsHub Logo
Followers 2
Posts 575
Boards Moderated 0
Alias Born 09/20/2011

Re: alternatepatel post# 18667

Thursday, 07/19/2018 2:59:09 AM

Thursday, July 19, 2018 2:59:09 AM

Post# of 20689
[Is it fair to value momenta's gHumira at $100m?]

I'm just lowballing it. Lower hurdle easier to jump over. Same thing with gCopaxone… MNTA will not get anything but crumbs.


[I think it's easily worth $500m+. The $50m patent dance may not be required now in light of MYL settlement. ]


Yep.. Yep... Yep!.. that's my kinda thinking...